A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Tolerability of TREXIMA* (Sumatriptan Succinate/Naproxen Sodium) for a Single Moderate or Severe Headache in Adults Diagnosed With Probable Migraine Without Aura (ICHD-II 1.6.1) (*TREXIMET)

Name: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Tolerability of TREXIMA* (Sumatriptan Succinate/Naproxen Sodium) for a Single Moderate or Severe Headache in Adults Diagnosed With Probable Migraine Without Aura (ICHD-II 1.6.1) (*TREXIMET)
Creator: Vivli
Published: 2018-10-27T11:55:27+08:00

DataCite Commons2024-12-02 更新2026-05-07 收录

偏头痛急性治疗

药物临床试验

数据链接：

https://search.vivli.org/doiLanding/studies/00000427/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

This study was designed to determine the efficacy and tolerability of TREXIMET (formerly known as TREXIMA) compared to placebo for the acute treatment of probable migraine, a sub-type of migraine.

提供机构：

Vivli

创建时间：

2018-10-27